Appendix Cancer Clinical Trial
Official title:
Genetics of Appendix Cancer: The GAP Study
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
The Genetics of Appendix Cancer (GAP) Study aims to analyze hereditary factors, tumor characteristics and clinical features/outcomes among adults diagnosed with appendix cancer and their biological parents. Patients are recruited at any time after a diagnosis of appendix cancer and followed for up to 6 years after study enrollment. This cohort is enriched by robust biospecimens and data collections. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05623787 -
Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms
|
N/A | |
| Active, not recruiting |
NCT05305820 -
Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy
|
N/A | |
| Recruiting |
NCT04907643 -
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
|
N/A | |
| Completed |
NCT04526886 -
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
|
N/A | |
| Recruiting |
NCT06216561 -
Intraperitoneal LSTA1 in CRS-HIPEC
|
Phase 1 | |
| Recruiting |
NCT05277766 -
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
|
Phase 1 | |
| Terminated |
NCT03287947 -
LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma
|
Phase 2 | |
| Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
| Active, not recruiting |
NCT04902872 -
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05919758 -
Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix
|
||
| Active, not recruiting |
NCT01815359 -
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
|
Phase 2 | |
| Not yet recruiting |
NCT06263088 -
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
|
N/A | |
| Completed |
NCT02833753 -
Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
|
Phase 1 | |
| Recruiting |
NCT05780684 -
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
|
N/A | |
| Recruiting |
NCT03210298 -
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
|
||
| Not yet recruiting |
NCT04634448 -
The Prevalence of Appendiceal Tumours in Periappendicular Abscess
|
N/A | |
| Active, not recruiting |
NCT04157322 -
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
|
||
| Completed |
NCT02489422 -
Programs To Support You During Chemotherapy
|
N/A |